Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Treatment of cancer using a CD33 chimeric antigen receptor

US Patent 10851166 · Granted Dec 1, 2020

Estimated economic value: $41,189,000

Assignee

Inventors

View full patent text on Google Patents →